Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma
- PMID: 19736056
- PMCID: PMC2808169
- DOI: 10.1016/j.canep.2009.08.005
Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma
Abstract
Background: We examined risk of multiple myeloma (MM) associated with variants in genes involved in metabolism and response to exogenous chemicals [cytochrome P450 enzymes (CYP1B1, CYP2C9), epoxide hydrolase (EPHX1), paraoxonase 1 (PON1), arylhydrocarbon hydroxylase receptor (AHR), and NAD(P)H:quinone oxidoreductase (NQO1)].
Methods: This study included 279 MM cases and 782 controls in a pooled analysis of two population-based case-control studies. One common variant from each candidate gene was genotyped using DNA from blood or buccal cells. We estimated risk of MM associated with each genotype, controlling for race, gender, study site, and age, using odds ratios (OR) and 95% confidence intervals (CI).
Results: Evaluations of the CYP1B1 V432L variant (rs1056836) suggested increased risk of MM among persons with the CG and GG genotypes compared to the CC genotype [OR (95% CI)=1.4 (1.0-2.0)]. Similar results were seen in analyses stratified by race and gender. We did not find any associations between MM and the CYP2C9, EPHX1, NQO1, or PON1 genes.
Conclusions: CYP1B1 activates chemicals such as polycyclic aromatic hydrocarbons and dioxins to create oxidized, reactive intermediates, and higher gene activity has been shown for the G allele. We conducted the largest analysis to date on MM and these genetic variants and our results provide preliminary evidence that variation in CYP1B1 may influence susceptibility to MM.
Similar articles
-
Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.Oncol Rep. 2010 Nov;24(5):1347-53. doi: 10.3892/or_00000992. Oncol Rep. 2010. PMID: 20878130
-
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.Neuro Oncol. 2006 Apr;8(2):145-55. doi: 10.1215/15228517-2005-003. Epub 2006 Jan 27. Neuro Oncol. 2006. PMID: 16598069 Free PMC article.
-
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.Carcinogenesis. 2002 Nov;23(11):1839-49. doi: 10.1093/carcin/23.11.1839. Carcinogenesis. 2002. PMID: 12419832
-
Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.Cancer Sci. 2004 Jan;95(1):1-6. doi: 10.1111/j.1349-7006.2004.tb03162.x. Cancer Sci. 2004. PMID: 14720319 Free PMC article. Review.
-
Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.Breast Cancer Res Treat. 2010 Jul;122(2):545-51. doi: 10.1007/s10549-009-0728-z. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054638 Review.
Cited by
-
Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.J Exp Clin Cancer Res. 2014 Sep 28;33(1):82. doi: 10.1186/s13046-014-0082-9. J Exp Clin Cancer Res. 2014. PMID: 25261893 Free PMC article.
-
Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.PLoS One. 2013 Jul 2;8(7):e68041. doi: 10.1371/journal.pone.0068041. Print 2013. PLoS One. 2013. PMID: 23844152 Free PMC article.
-
Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma.Meta Gene. 2013 Oct 28;1:93-101. doi: 10.1016/j.mgene.2013.09.007. eCollection 2013 Dec. Meta Gene. 2013. PMID: 25606379 Free PMC article.
-
Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.PLoS One. 2013 Apr 18;8(4):e62119. doi: 10.1371/journal.pone.0062119. Print 2013. PLoS One. 2013. PMID: 23637977 Free PMC article. Clinical Trial.
-
Drug metabolism and clearance system in tumor cells of patients with multiple myeloma.Oncotarget. 2015 Mar 20;6(8):6431-47. doi: 10.18632/oncotarget.3237. Oncotarget. 2015. PMID: 25669983 Free PMC article.
References
-
- Altieri A, Chen B, Bermejo JL, Castro F, Hemminki K. Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer. 2006;42:1661–1670. - PubMed
-
- Lynch HT, Sanger WG, Pirruccello S, Quinn-Laquer B, Weisenburger DD. Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst. 2001;93:1479–1483. - PubMed
-
- Mccrea AP, Morris TC. Concurrent familial myeloma in northern Ireland. Cancer. 1986;58:394–396. - PubMed
-
- De Roos AJ, Baris D, Weiss NS, Herrinton L. Epidemiology of multiple myeloma. In: Malpas JS, Bergsagel D, Kyle RA, Anderson DC, editors. Multiple myeloma. Elsevier, Inc; 2004.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous